Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Turcot syndrome × spartalizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 6 Neoplasm Metastasis 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Turcot syndrome 1 Thrombocythemia, Essential 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Myeloproliferative Disorders 1 Lung Neoplasms 1 Lung Diseases 1 Hemangiosarcoma 1 Colorectal Neoplasms 1 Adenocarcinoma of Lung 1 Adenocarcinoma 1

Interventions

spartalizumab 1 Specimen Handling 1 Nivolumab 1 Ipilimumab 1 CTLA-4 Antigen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04001101 2021-11-30

Anti-PD-1 +/- RT for MSI-H Solid Tumors

University of Colorado, Denver

Phase 2 Withdrawn

Gastrointestinal

Turcot syndrome, Neoplasm Metastasis, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡